ARCA:XBI
State Street SPDR S&P Biotech ETF | |
| $ 156.2 -0.62 ( -0.4%) 04:00 PM EST | |
PE Ratio:
17.14
PB Ratio:
4.9
Volume:
7.86M
Dividend Yield %:
0.37
| |
| Last Holding update 2026-08-28 | 152 Stocks (23 new) |
| Value $10.72 Bil | Turnover 23 % |
Registrant: State Street(R) SPDR(R) S&P(R) Biotech ETF
| |
Year: 2026
GuruFocus Rankings
Financial Strength
6 /10
Profitability Rank
3 /10
GF Value Rank
3 /10
Growth Rank
7 /10
Momentum Rank
6 /10
State Street SPDR S&P Biotech ETF Geographic Breakdown
State Street SPDR S&P Biotech ETF Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
State Street SPDR S&P Biotech ETF Key Statistics
| Name | Value | ||
|---|---|---|---|
| Day's Open ($) | 158.27 | ||
| Day's Range ($) | 156.13 - 159.6607 | ||
| Day's Volume | 7,861,290 | ||
| 52-Week Range ($) | 92.64 - 169.89 | ||
| Beta | 1.1245 | ||
| 3-Year Sharpe Ratio | 0.89 | ||
| 3-Year Sortino Ratio | 1.63 | ||
| Volatility | 23.09 | ||
| 14-Day RSI | 43.14 | ||
| 14-Day ATR ($) | 4.052259 | ||
| 20-Day SMA ($) | 163.1215 |
Fundamental Data
| Name | Value | ||
|---|---|---|---|
| Market Cap (Mil $) | 10,894.95 | ||
| Shares Outstanding (Mil) | 69.75 | ||
| PE Ratio | 17.14 | ||
| PE Ratio (10y Range) | 14.4 - 37.15 | ||
| PE Ratio (10y Median) | 18.3 | ||
| PB Ratio | 4.9 | ||
| PB Ratio (10y Range) | 2.75 - 6.29 | ||
| PB Ratio (10y Median) | 4.27 |
Dividend Data
| Name | Value | ||
|---|---|---|---|
| Dividends per Share (TTM) ($) | 0.579 | ||
| Dividend Yield % | 0.37 | ||
| Dividend Yield % (10y Range) | 0.01 - 0.52 | ||
| Dividend Yield % (10y Median) | 0.23 | ||
| Next Dividend Payment Date | |||
| Dividend Frequency | Quarterly |
XBI State Street SPDR S&P Biotech ETF Fundamental Charts
Historical TTM Price-to-Earnings for XBI State Street SPDR S&P Biotech ETF
Historical TTM Price-to-Earnings without NRI for XBI State Street SPDR S&P Biotech ETF
Historical Price-to-Book Ratio for XBI State Street SPDR S&P Biotech ETF
Historical Dividend Yields for XBI State Street SPDR S&P Biotech ETF
State Street SPDR S&P Biotech ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with ARCA:XBI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ARCA:XBI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
State Street(R) SPDR(R) S&P(R)... Top Holdings of 2026-06-30
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
APGE | Apogee Therapeutics Inc | 1,203,674 | 159,763.6 | +49.42% | 1.490 | +0.49% | 1.590 | +60.43% | +78.95% | 10,223.1 | Biotechnology | |
MRNA | Moderna Inc | 2,164,892 | 151,607.4 | -35.15% | 1.410 | -0.44% | 0.540 | +190.03% | +388.20% | 57,478.0 | Biotechnology | |
TWST | Twist Bioscience Corp | 1,469,111 | 151,142.1 | -22.40% | 1.410 | -0.17% | 2.340 | +71.80% | +301.07% | 8,424.9 | Biotechnology | |
ORKA | Oruka Therapeutics Inc | 1,555,002 | 147,989.5 | +143.86% | 1.380 | +0.81% | 2.350 | +34.92% | +204.78% | 6,111.8 | Biotechnology | |
KYMR | Kymera Therapeutics Inc | 1,272,754 | 145,946.7 | +30.26% | 1.360 | +0.32% | 1.530 | +38.57% | +47.74% | 9,564.8 | Biotechnology | |
VKTX | Viking Therapeutics Inc | 3,587,998 | 139,967.8 | +38.96% | 1.310 | +0.37% | 3.080 | +11.78% | -9.10% | 3,730.6 | Biotechnology | |
PRAX | Praxis Precision Medicines Inc | 413,737 | 138,515.0 | +11.70% | 1.290 | +0.14% | 1.480 | +34.92% | +13.52% | 9,328.1 | Biotechnology | |
ERAS | Erasca Inc | 7,447,165 | 136,432.1 | +243.04% | 1.270 | +0.90% | 2.130 | +13.35% | +326.88% | 5,557.7 | Biotechnology | |
RVMD | Revolution Medicines Inc | 690,499 | 129,316.6 | -44.51% | 1.210 | -0.57% | 0.320 | +36.55% | +155.83% | 43,675.3 | Biotechnology | |
RYTM | Rhythm Pharmaceuticals Inc | 1,161,672 | 128,980.4 | +25.59% | 1.200 | +0.24% | 1.690 | +19.45% | -2.18% | 7,217.1 | Biotechnology |
State Street(R) SPDR(R) S&P(R) Biotech ETF's Historical Top Holdings Breakdowns
State Street(R) SPDR(R) S&P(R) Biotech ETF's Top Stock Picks
View Full List
| Ticker |
|---|
| FOLD Unlock Delisted |
SLS |
| ACLX Unlock Delisted |
| SLNO Unlock Delisted |
| APLS Unlock Delisted |
ERAS |
ORKA |
INSM |
RVMD |
RLAY |
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FOLD Unlock Delisted | Amicus Therapeutics Inc | 2026-06-30 | Sold Out Sold Out | -1.49% | 14.44 ($14.46) 14.49 | $14.49 | 0.21% | Sold Out | 0 | -8,213,589 | |
SLS | SELLAS Life Sciences Group Inc | 2026-06-30 | New Buy New Buy | +1.19% | 4.13 ($6.86) 15.45 | $11.54 | 68.29% | New holding | 8,654,720 | 8,654,720 | |
| ACLX Unlock Delisted | Arcellx Inc | 2026-06-30 | Sold Out Sold Out | -0.96% | 114.72 ($114.93) 115.1 | $115.07 | 0.12% | Sold Out | 0 | -1,158,034 | |
| SLNO Unlock Delisted | Soleno Therapeutics Inc | 2026-06-30 | Sold Out Sold Out | -0.94% | 33.48 ($51.34) 53.01 | $53.01 | 3.25% | Sold Out | 0 | -1,592,549 | |
| APLS Unlock Delisted | Apellis Pharmaceuticals Inc | 2026-06-30 | Sold Out Sold Out | -0.92% | 40.23 ($40.86) 41.12 | $41.03 | 0.42% | Sold Out | 0 | -2,856,301 | |
ERAS | Erasca Inc | 2026-06-30 | Add Add | +0.90% | 9.11 ($14.33) 22.47 | $15.89 | 10.89% | Add 243.04% | 7,447,165 | 5,276,221 | |
ORKA | Oruka Therapeutics Inc | 2026-06-30 | Add Add | +0.81% | 49.05 ($66.35) 95.17 | $92.31 | 39.13% | Add 143.86% | 1,555,002 | 917,346 | |
INSM | Insmed Inc | 2026-06-30 | Add Add | +0.57% | 91.88 ($121.76) 164.86 | $129.41 | 6.28% | Add 112.31% | 1,083,724 | 573,276 | |
RVMD | Revolution Medicines Inc | 2026-06-30 | Reduce Reduce | -0.57% | 95.36 ($145.29) 192.62 | $203.77 | 40.25% | Reduce -44.51% | 690,499 | -553,883 | |
RLAY | Relay Therapeutics Inc | 2026-06-30 | Add Add | +0.54% | 9.95 ($14.44) 19.74 | $18.87 | 30.68% | Add 96.38% | 6,304,701 | 3,094,268 |
State Street(R) SPDR(R) S&P(R) Biotech ETF Total Holding History ($B)
State Street(R) SPDR(R) S&P(R) Biotech ETF's Asset Allocation
State Street(R) SPDR(R) S&P(R) Biotech ETF Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
State Street(R) SPDR(R) S&P(R) Biotech ETF's Hypothetical Growth since 2026-06-30
State Street(R) SPDR(R) S&P(R) Biotech ETF's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
State Street(R) SPDR(R) S&P(R) Biotech ETF's Holdings Heat Map
Size field: